title: Brca2 is required for embryonic cellular proliferation in the mouse.
abstract: Mutations of the tumor suppressor gene BRCA2 are associated with predisposition to breast and other cancers. Homozygous mutant mice in which exons 10 and 11 of the Brca2 gene were deleted by gene targeting (Brca2(10-11)) die before day 9.5 of embryogenesis. Mutant phenotypes range from severely developmentally retarded embryos that do not gastrulate to embryos with reduced size that make mesoderm and survive until 8.5 days of development. Although apoptosis is normal, cellular proliferation is impaired in Brca2(10-11) mutants, both in vivo and in vitro. In addition, the expression of the cyclin-dependent kinase inhibitor p21 is increased. Thus, Brca2(10-11) mutants are similar in phenotype to Brca1(5-6) mutants but less severely affected. Expression of either of these two genes was unaffected in mutant embryos of the other. This study shows that Brca2, like Brca1, is required for cellular proliferation during embryogenesis. The similarity in phenotype between Brca1 and Brca2 mutants suggests that these genes may have cooperative roles or convergent functions during embryogenesis.
authors.affiliation: Amgen Institute, Toronto, Ontario, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Suzuki
authors.forename: J L
authors.initials: JL
authors.lastname: de la Pompa
authors.forename: R
authors.initials: R
authors.lastname: Hakem
authors.forename: A
authors.initials: A
authors.lastname: Elia
authors.forename: R
authors.initials: R
authors.lastname: Yoshida
authors.forename: R
authors.initials: R
authors.lastname: Mo
authors.forename: H
authors.initials: H
authors.lastname: Nishina
authors.forename: T
authors.initials: T
authors.lastname: Chuang
authors.forename: A
authors.initials: A
authors.lastname: Wakeham
authors.forename: A
authors.initials: A
authors.lastname: Itie
authors.forename: W
authors.initials: W
authors.lastname: Koo
authors.forename: P
authors.initials: P
authors.lastname: Billia
authors.forename: A
authors.initials: A
authors.lastname: Ho
authors.forename: M
authors.initials: M
authors.lastname: Fukumoto
authors.forename: C C
authors.initials: CC
authors.lastname: Hui
authors.forename: T W
authors.initials: TW
authors.lastname: Mak
mesh_terms: D000818:Animals; D024682:BRCA2 Protein; D002455:Cell Division / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics; D004622:Embryo, Mammalian / Q000166:cytology*; D005314:Embryonic and Fetal Development / Q000235:genetics; D005260:Female; D018507:Gene Expression Regulation, Developmental; D006579:Heterozygote; D008648:Mesoderm; D051379:Mice; D008817:Mice, Mutant Strains; D009363:Neoplasm Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics; D051135:Rad51 Recombinase; D014157:Transcription Factors / Q000235:genetics*; D014327:Trophoblasts
chemical_list: D024682:BRCA2 Protein; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D014157:Transcription Factors; D051135:Rad51 Recombinase; C495154:Rad51 protein, mouse; D016283:Proto-Oncogene Proteins p21(ras)